The Landscape of Alteration of DNA Integrity-Related Genes and Their Association with Tumor Mutation Burden in Non-Small Cell Lung Cancer

被引：0
|
作者：
Sharpnack, M. [1 ]
Cho, J. H. [2 ]
Oezkan, F. [2 ]
Koenig, M. [1 ]
Kim, I. [3 ]
Otterson, G. [2 ]
Huang, K. [4 ]
Carbone, D. [2 ]
He, K. [2 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Ohio State Univ, Comprehens Canc Ctr, Dept Med, Columbus, OH 43210 USA
[3] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[4] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Mutation burden; DNA integrity; NSCLC;
D O I：
10.1016/j.jtho.2017.09.435
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA 18.02
引用
收藏
页码：S1795 / S1796
页数：2
相关论文
共 50 条
  • [1] Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer
    Wang, Xinan
    Ricciuti, Biagio
    Tom Nguyen
    Li, Xihao
    Rabin, Michael S.
    Awad, Mark M.
    Lin, Xihong
    Johnson, Bruce E.
    Christiani, David C.
    CANCER RESEARCH, 2021, 81 (09) : 2566 - 2573
  • [2] Association of tumor mutational burden with smoking and mutation status in non-small cell lung cancer (NSCLC).
    Davis, Andrew A.
    Chae, Young Kwang
    Agte, Sarita
    Pan, Alan
    Mohindra, Nisha Anjali
    Villaflor, Victoria Meucci
    Giles, Francis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [3] Tumor mutation burden as emerging biomarker in non-small cell lung cancer and beyond
    Fischer, Rieke N.
    Wolf, Juergen
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S770 - S773
  • [4] Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer
    Sharpnack, Michael F.
    Cho, Ju Hwan
    Johnson, Travis S.
    Otterson, Gregory A.
    Shields, Peter G.
    Huang, Kun
    Carbone, David P.
    He, Kai
    LUNG CANCER, 2020, 146 : 36 - 41
  • [5] Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer
    Cai, Liangliang
    Bai, Hua
    Duan, Jianchun
    Wang, Zhijie
    Gao, Shugeng
    Wang, Di
    Wang, Shuhang
    Jiang, Jun
    Han, Jiefei
    Tian, Yanhua
    Zhang, Xue
    Ye, Hao
    Li, Minghui
    Huang, Bingding
    He, Jie
    Wang, Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [6] Tumor immunity landscape in non-small cell lung cancer
    Yu, Xiaoqing
    Wang, Xuefeng
    PEERJ, 2018, 6
  • [7] The landscape of intra-tumor heterogeneity (ITH) and its association with actionable mutation and blood tumor mutation burden (bTMB) in patients with non-small cell lung cancer (NSCLC) assessed by circulating tumor DNA (ctDNA)
    Kim, Leeseul
    Lee, Yeun Ho
    Kim, Hye Sung
    Choi, Horyun
    Kim, Jinah
    Chae, Young Kwang
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Genetic and Epigenetic Alterations are Associated with Tumor Mutation Burden in Non-Small Cell Lung Cancer
    Cai, L.
    Bai, H.
    Wang, Z.
    Wang, S.
    Duan, J.
    Gao, S.
    He, J.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S377 - S377
  • [9] The Implication of Frameshift Mutation Burden in Neoantigen and Immune Cell Landscape in Non-Small Cell Lung Cancer (NSCLC)
    Chae, Y.
    Chang, S.
    Ko, T.
    Rhee, K.
    Cruz, M.
    Bhave, M.
    Anker, J.
    Davis, A.
    Lams, W.
    Wang, V.
    Chuang, J.
    Park, L. C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S535 - S535
  • [10] Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients
    Zhang, H.
    Deng, Y-M
    Chen, Z-C
    Tang, Y-C
    Yang, S.
    Zhang, S-D
    Liang, J-M
    Wang, Y-G
    Wu, X.
    Zhang, R-W
    Feng, W-N
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (14) : 7664 - 7672
12345